MarketWatch: Health Roundup

Product Code DAT00285
Publication Date November 2008
Publisher Datamonitor
Product Type Report
Pages 54
ISBN Number not applicable
Change currency
PDF £255.00 €307 $403 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

MarketWatch: Health Roundup

Datamonitor's MarketWatch Health Roundup is a onestop news shop for timepressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Healthcare industry.

Contents

  • In This Month's Marketwatch
    • Pharmaceutical Company RoundUp
    • Cancer Update
    • News RoundUp
    • Feature Analysis: Targeted Therapy Cancer Brands To Achieve Sales Of Over $42 Billion By 2017
    • Opinion: Imclone/Bms/Merck Serono: Erbitux To Fortify Hold On The Head And Neck Cancer Market
    • Opinion: Eli Lilly: Alimta Receives Us Green Light For Lung Cancer
    • Opinion: Genentech/Roche: Disappointing Data May Not Spell The End For Avastin/Tarceva Combination
    • Opinion: Glaxosmithkline: New Data Suggest Potential For Tykerb Indication Expansion
    • Cardiovascular Update
    • News RoundUp
    • Central Nervous System Update
    • News RoundUp
    • Opinion: Medicinova: Promising Ms Drug Remains In The Shop Window
    • Idi Update
    • News RoundUp
    • Opinion: SanofiAventis: Nasacort Catches Up With Competitors
    • Opinion: Merck & Co: Strengthens Osteoporosis Pipeline Amid Falling Fosamax Sales
    • Opinion: Centocor/Johnson & Johnson: Sonic Trial Results Support Remicade
    • Infectious Diseases Update
    • News RoundUp
    • Industry Update
    • Feature Analysis: Key Decision Makers Will Shape The Biosimilars Landscape
    • Feature Analysis: Battle For Hiv Drug Market Share Getting Fiercer
    • Feature Analysis: Opportunity Knocks For Big Pharmaceutical Companies In The Credit Crunch
    • Opinion: SanofiAventis: Persisting In Zentiva Bid
    • Company Spotlight
    • Pfizer
    • Biotechnology Update
    • News RoundUp
    • Feature Analysis: Barack Obama's Stance On Stem: A Big Win For Life Science Research And It
    • Opinion: Biosimilars: Us Presidential Candidates Pledge Support
    • Opinion: Amgen/Wyeth/Takeda: New Data To Boost Enbrel's Position
    • Biotechnology Company Spotlight
    • Neose Technologies
    • Further Reading
    • Index
    • Pharma Companies
    • Biotech Companies
    • Key Drugs